Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy-Reference-Cited by-同舟云学术

Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy

Published:2020 Issue:12 Volume:8 Page:2410-2417
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Wang Qingbing¹²³⁴⁵,Zhu Xingjun⁶⁷⁸⁹⁵,Wu Zhiyuan¹²³⁴⁵,Sun Tao¹⁰¹¹¹²¹³¹⁴,Huang Wei¹²³⁴⁵,Wang Zhongmin¹²³⁴⁵,Ding Xiaoyi¹²³⁴⁵,Jiang Chen¹⁰¹¹¹²¹³¹⁴^ORCID,Li Fuyou⁶⁷⁸⁹⁵^ORCID

Affiliation:

1. Department of Interventional Radiology

2. Ruijin Hospital

3. Shanghai Jiao Tong University School of Medicine

4. Shanghai 200025

5. China

6. Institute of Biomedical Sciences

7. Department of Chemistry

8. Fudan University

9. Shanghai 200433

10. Key Laboratory of Smart Drug Delivery

11. Ministry of Education

12. State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science

13. Department of Pharmaceutics

14. School of Pharmacy

Abstract

A lanthanide-based visualizable photothermal controlled drug release nanosystem was developed to overcome the drug resistance of gemcitabine for pancreatic cancer.

Funder

Shanghai Municipal Health Bureau

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2020/TB/D0TB00017E

Reference39 articles.

1. Global cancer statistics, 2012

2. Pancreatic cancer

3. Pancreatic Adenocarcinoma

4. Improvement of surgical results for pancreatic cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches;Environmental Research;2024-01

2. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival;Biomedicine & Pharmacotherapy;2023-09

3. Nanomaterials assisted chemo-photothermal therapy for combating cancer drug resistance;Journal of Drug Delivery Science and Technology;2022-04

4. Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies;Theranostics;2022

5. Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance;Cancers;2021-12-07